NCT06960278

Brief Summary

The evaluation of recurrent aphthous stomatitis (RAS) was performed by an oral medicine specialist, who relied on the clinical manifestations of the condition. The experimental group was administered 1x1cm mucosal patches containing alum stone at a concentration of 7%, whereas the control group was given placebo patches without any active medication. Size of aphthous lesions and degree of pain assessed at days 1, 3, and 5. Statistical analysis was performed with repeated measures ANOVA using R software.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started Feb 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 5, 2021

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 2, 2023

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

February 15, 2025

Completed
3 months until next milestone

First Posted

Study publicly available on registry

May 7, 2025

Completed
Last Updated

May 7, 2025

Status Verified

April 1, 2025

Enrollment Period

1.7 years

First QC Date

February 15, 2025

Last Update Submit

April 28, 2025

Conditions

Keywords

Alum stoneaphthous ulcermucosal adhesive patches

Outcome Measures

Primary Outcomes (1)

  • Lesion Size

    1, 3, 5 day

Study Arms (3)

A Randomized Double-blinded Placebo-controlled Clinical Trial

PLACEBO COMPARATOR

The experimental group was administered 1x1cm mucosal patches containing alum stone at a concentration of 7%, whereas the control group was given placebo patches without any active medication

Procedure: Size of aphthous lesions and degree of pain assessed at days 1, 3, and 5.Procedure: Control

Control

EXPERIMENTAL
Procedure: Size of aphthous lesions and degree of pain assessed at days 1, 3, and 5.Procedure: Control

Placebo

PLACEBO COMPARATOR

hundred female from the patients of oral diagnosis clinic in college of dentistry and from the privet clinic

Device: ALUMSTONE

Interventions

Size of aphthous lesions and degree of pain assessed at days 1, 3, and 5.

A Randomized Double-blinded Placebo-controlled Clinical TrialControl
ControlPROCEDURE

The dimensions of the lesion were measured by oral medicine specialists using a flexible ruler

A Randomized Double-blinded Placebo-controlled Clinical TrialControl
ALUMSTONEDEVICE

alum administration via adhesive patches on the healing process of aphthous ulcers

Placebo

Eligibility Criteria

Age22 Years - 35 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Iraq, Anbar, Ramadi, 72300

Anbar, Al-Anbar Governorate, 72300, Iraq

Location

Related Links

MeSH Terms

Conditions

Sutton disease 2Stomatitis, Aphthous

Condition Hierarchy (Ancestors)

StomatitisMouth DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: In this study one hundred female, aged between twenty-two and thirty years, reported multiple oral aphthous ulcers. The evaluation of recurrent aphthous stomatitis (RAS) was performed by an oral medicine specialist, who relied on the clinical manifestations of the condition. The experimental group was administered 1x1cm mucosal patches containing alum stone at a concentration of 7%, whereas the control group was given placebo patches without any active medication. Size of aphthous lesions and degree of pain assessed at days 1, 3, and 5. Statistical analysis was performed with repeated measures ANOVA using R software
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Marwan Mahmood Saleh

Study Record Dates

First Submitted

February 15, 2025

First Posted

May 7, 2025

Study Start

February 5, 2021

Primary Completion

October 15, 2022

Study Completion

March 2, 2023

Last Updated

May 7, 2025

Record last verified: 2025-04

Locations